When a lead at Wellcome can vouch for this then boom23 Jul 2020 18:52
Dr Nick Cammack, COVID-19 Therapeutics Accelerator Lead at Wellcome, said:
“Having a wide range of effective COVID-19 treatments is essential. Once the results reported by Synairgen are confirmed, then the signs look promising and could be a significant step forward in COVID-19 treatment research.